MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Pain as a Risk Factor for Developing Depression among Patients with Parkinson’s Disease: A Systematic Review of 1426 patients

    S. Mohammed, A. Eldeen (Sohag, Egypt)

    Objective: This systematic review aims mainly to investigate pain as an independent risk factor for developing depressive symptoms among patients with PD. Background: Parkinson's disease…
  • 2023 International Congress

    Pseudogout Mimicking Stiffness in Parkinson’s Disease: A Case Report

    S. Kazanci, M. Afshari, J. Fleisher (Chicago, USA)

    Objective: N/A Background: Levodopa-responsive muscular rigidity is one of the hallmarks of Parkinson’s disease (PD). Many rheumatological conditions can present with stiffness1-4. For example, polymyalgia…
  • 2023 International Congress

    Deep brain stimulation for movement disorders: Assessing disparities in access to care

    Z. Rifi, M. Harary, L. Remore, K. Fu, A. Bari (Los Angeles, USA)

    Objective: To investigate the impact of non-disease related factors (sex, race, age, language, or socioeconomic status) on the likelihood of movement disorders patients receiving Deep…
  • 2023 International Congress

    A comparative study of non-motor symptoms in Huntington’s disease and Parkinson’s disease

    WZ. Hu, JH. Yin, LX. Cao, Y. Huang (Beijing, China)

    Objective: To assess and compare the non-motor symptoms (NMS) profile in Parkinson's disease (PD) and Huntington's disease (HD) patients using Parkinson's Disease Non-Motor Symptom Rating…
  • 2023 International Congress

    Assessing the swallow tail sign in clinical practice

    MA. Ruiz Yanzi, E. Natera-Villalba, JA. Pineda-Pardo, M. Matarazzo (Madrid, Spain)

    Objective: To evaluate the swallow tail sign accuracy to distinguish between essential tremor (ET) and Parkinson’s disease (PD) in clinical practice.  Background: The swallow tail…
  • 2023 International Congress

    How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the Phase 3 clinical trial

    R. Hauser, G. Banisadr, S. Fisher, H. Visser, R. D'Souza (Tampa, USA)

    Objective: To provide guidance on dosing of IPX203 based on clinical trial experience. Background: IPX203 is an extended-release, oral carbidopa-levodopa (CD-LD) formulation designed to rapidly…
  • 2023 International Congress

    A validation study of the Mini-BESTest in a Spanish population with Parkinson’s disease.

    A. García Bustillo, F. Valiñas Sieiro, M. Allende Río, A. Olivares Gil, JL. Garrido Labrador, JM. Ramírez Sanz, M. Jahouh, A. Arnaiz González, JF. Díez Pastor, N. Mariscal, S. Calvo Simal, J. Rivadeneyra-Posadas, L. Simón Vicente, J. González Santos, JJ. González Bernal, JM. Gabriel Galán, E. Cubo (Burgos, Spain)

    Objective: Because the Mini Balance Evaluation Systems Test (Mini-BESTest) is widely used, our aim was to validate the Spanish version in PD. Background: Parkinson's disease…
  • 2023 International Congress

    The Effects of Motor Imagery Therapy in the rehabilitation of patients with Parkinson’s Disease: A Systematic Review

    A. Ibrahim Abdelhamed, M. Abdeen, H. Elkhodary, A. Samir, A. El-Shazly, M. Zaghloul, A. Abdelmalek, E. Elbathesh, R. Salem, A. Mohamed, A. Ashour, M. Fahmy, H. Samy, M. Shafiek Saleh (Elfashn, Egypt)

    Objective: This systematic review summarizes all published outcomes of Parkinson’s patients treated with Motor Imagery Therapy. Background: Parkinson's disease (PD) is one of the most…
  • 2023 International Congress

    Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: This exploratory trial aims to compare treatment outcomes of adding one daily dose of opicapone (OPC) 50 mg versus an additional dose of levodopa…
  • 2023 International Congress

    Sub-cellular alterations in MPTP-induced in-vivo and in-vitro systems and Non-MPTP human Parkinsonian skin biopsies: Verifying the sequelae of differential toxicity

    P. Alladi, B. Bhaduri, S. Rashmi, I. Datta, P. Pal, D. Srinivas, R. Yadav (Bangalore, India)

    Objective: To evaluate the possible temporal hierarchy of sub-cellular organellar degeneration in experimental models of Parkinson’s disease (PD), using MPTP/MPP+ Background: Higher prevalence of PD in…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley